0122: The serotonergic system in pathological human cardiac valves. What is the role of progenitors cells expressing the 5-HT2B receptor?  by Ayme-Dietrich, Estelle et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2014) 6, 72-73 73
cases of isolated MVP. In a family suffering a mild form of MVP, we found
a non-synonymous rare variant in the Rac1 specific GTPase Activating Pro-
tein ARHGAP24 gene encoding ARHGAP24-D92N mutant protein. Interest-
ingly, ARHGAP24 protein was previously shown to interact with FlnA and
was thus named FilGAP. Also, our previous studies established the potential
involvement of FilGAP and small GTPases (RhoA, Rac1) in FlnA-associated
MVP. Complete exon sequencing of ARHGAP24 in 95 additional MVP
patients identified, according to genetic databases, 3 other non-synonymous
rare sequence variations encoding FilGAP-R95Q; P417H and T481M mutants.
Based on this genetic analysis, HEK293 cells were used to analyze the effects
of theses mutations. The role of FilGAP is to decrease Rac1 activity and we
showed that all the mutations identified are loss of function mutations mutated
leading to increase Rac1 activity. Increased spreading of mutant FilGAP
expressing cells corroborates this increase in Rac activity. In addition, we
showed FlnA poorly co-immunoprecipitates FilGAP-P417H and T481M sug-
gesting reduced FlnA/FilGAP interaction might be the molecular mechanism
responsible for the loss of function of these two mutations. The molecular
mechanism involved for the two other mutations (R92Q and D92N) is under
investigations. Together, we identified a new gene involved, like FlnA, in cel-
lular mechanical stress response pathway suggesting common physiopatholog-
ical mechanisms are at work in FilGAP and FlnA associated valvulopathy.
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Many compounds (pergolide, cabergoline, fenfluramine, ectasy) were
described as inducers of fibrotic valvular lesions, a rare but severe drug reac-
tion. All these drugs share in common the pharmacological property to acti-
vate a serotonergic receptor subtype, the 5HT2B. Together with the well
known “carcinoid heart” that is a valvulopathy due to high amounts of circu-
lating serotonin, these observations lead to the hypothesis that cardiac valves
express a "serotonergic system" that could be activated by 5-HT or 5-HTR
agonists. The aim of this work was to characterize the pattern of expression of
5-HT2A,2B,4 receptors, the serotonin transporter (SERT) and the biosynthesis
peripheral enzyme (Tph1) in various valvulopathies. Thirty degenerated
human valves were collected: 11 calcified aortic valves (CAV), 5 sclerotic
aortic valves (SAV), 11 dystrophic mitral valves (DMV). They were analyzed
by RT-qPCR and immunohistochemistery. All samples express 5HT2A,2B,4
receptors, SERT and Tph1. In these valve tissues, the amount of 5HT2B
receptor (5HT2B R) mRNA is higher than the 5HT2A one (5HT2A R) : Δ Ct
(5HT2B R -18S) = 12,53±1,12 vs Δ Ct (5HT2A R -18S) = 15,95±2,37 for
CAV, Δ Ct (5HT2B R -18S) = 13,04±2,62 vs Δ Ct (5HT2A R -
18S)=16,00±1,46 for SAV, Δ Ct (5HT2B R -18S) = 12,34±0,77 vs Δ Ct
(5HT2A R -18S) = 16,14±0,86 for DMV. The amounts of SERT, Tph1 and
5HT4 receptor mRNA are negligible whatever valve and etiology. At a topo-
graphical point of view, 5HT2BR expression is found in endothelial cells (at
the valve surface) but also inside valve lesions, by interstitial cells (smooth
muscle α-actin and vimentin positive cells) located in an abundant glycosami-
noglycan matrix. Characterization of these cells is in progress. In particular,
we characterize the high amount CD34+ hematopoietic progenitors that are
highly present in fibromyxoid lesions. To summarize, 5HT2A,2B,4 receptors,
SERT and Tph1 are expressed in aortic and mitral diseased valves. The
amounts of 5HT2A,2B R mRNA are equal between mitral and aortic valves.
The contribution of the two 5-HT2 receptors in valve degeneration is now
under investigation whatever the pathological process considered.
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Purpose: Aortic Valve Stenosis (AVS) affects 2% to 6% of population
over 65 years in industrialized countries. This atherosclerosis-like pathology
involves Valve Interstitial Cell (VIC) proliferation and commitment to osteo-
blast-like cells. This prevalent cell type of aortic valve presents five identifi-
able phenotypes: embryonic progenitor endothelial/mesenchymal cells,
progenitor, quiescent, activated and osteoblastic VICs. To study the patho-
physiology of AVS, their in vitro cultures are frequently used. Our purpose is
to characterize VICs isolated from normal and fibrocalcified human aortic
valves and analyze their in vitro behavior.
Methods: We collected 5 normal and 5 fibrocalcified human aortic valves.
VICs were isolated by collagenase digestion. Characterization is assessed at
different passages (2 to 5) by immunofluorescence. Analyzed markers consist
of progenitor cell markers (SSEA4, ABCG2, CD90, NG2 and OsteoBlast
CaDHerin (OB-CDH)), fibroblast markers (vimentin and HSP47) and smooth
muscle cell (SMC) marker (α-actin). By blue trypan and MTS, we compared
the viability and proliferation of VICs in standard and starvation medium at
48 hours.
Results: Independently of their origin, VICs express all progenitor cell
markers. Fibroblasts markers are expressed twice more by pathological VICs
and four times more for SMC marker. In standard medium, VICs viability is
similar (96,7±2,4 % vs 96,4±2,3 % ; normal vs pathological ± SEM). Patho-
logical VICs proliferate more than normal VICs (2,2±0,7 vs 1,6±0,4 ; OD/OD
control). In starvation medium, viability is significantly reduced for patholog-
ical VICs (89,6±7,9 % vs 76,5±5,3 %) but still proliferate in opposition with
normal VICs (1,7±0,6 vs 1,2±0,3).
Conclusion: All VICs phenotypes are found in vitro with no culture selec-
tion but in different ratios according to their origin. These new data in VICs
isolated from normal or pathological human aortic valves allow us to approve
their use in vitro.
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